
Gaudium IVF Reports Q1 FY27 Results; Revenue Grows 9.13% Amid Expansion Investment
Gaudium IVF and Women Health Limited, a prominent fertility and women's healthcare provider in India, announced its unaudited financial results for the quarter ended June 30, 2026. The company also highlighted significant operational expansions, including commencing operations at a new IVF hub in New Delhi and receiving Board approval for a new hospital project in Lucknow.The Q1 FY27 performance showed revenue growth, though profitability saw fluctuations as the company continued strategic investments ahead of its expansion plans.
Consolidated Financial Performance
The financial highlights across Q1 FY27 compared to Q1 FY26 are detailed below:| Particulars | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Revenue from Operations | 19.38 Cr | 17.76 Cr | 9.13% |
| EBITDA | 2.42 Cr | 5.15 Cr | -52.96% |
| EBITDA Margin % | 12.51% | 29.02% | -1651 bps |
| Profit After Tax (PAT) | 1.8 Cr | 3.1 Cr | -42.27% |
| PAT Margin % | 9.17% | 17.33% | -816 bps |
Note: PAT represents Profit After Tax from continuing operations.
Operational Milestones and Growth Drivers
The company commenced commercial operations at its new IVF Centre/Hub in South Extension Part-II, New Delhi, marking the first step toward a planned 19-centre expansion. This hub features the Gaudium Signature Lab, which utilizes AI-powered embryology tools (SiD and ERICA).Simultaneously, the Board approved the development of "Gaudium Women Hospital" in Lucknow, Uttar Pradesh, through a 30-year land lease with an estimated project cost up to ₹15 crore. This approval marks the company's entry into the state.
As per the Key Metrics report, Gaudium IVF has expanded its network to include 8 hubs and 28 spokes. The company reports delivering a clinical pregnancy success rate of 62% on the first IVF attempt.
Management Commentary on Performance
Dr. Manika Khanna, Chairperson and Managing Director of Gaudium IVF and Women Health Limited, addressed the quarter's performance. She stated that Q1 FY27 was a period of "measured progress," noting that revenue growth of 9.13% reflected the resilience of mature hubs and steady patient flow seeking advanced fertility care.Dr. Khanna attributed profitability moderation to conscious investments made in preparation for future expansion, including recruiting clinical talent and implementing necessary systems. She emphasized that these expenditures precede the revenue they support but are a calculated trade-off given the significant runway ahead.
She also noted the strategic progress, mentioning the Board approval for the Lucknow hospital project. Looking forward, Dr. Khanna confirmed that while one hub is now operational at South Extension, others remain in progression toward the planned expansion road map across FY27 and FY28.
Company Overview
Gaudium IVF and Women Health Limited, established in 2009, offers advanced reproductive solutions and holistic care through centers located in Delhi, Mumbai, Bangalore, Patna, Ludhiana, and Srinagar. The company provides a comprehensive range of services including IVF, ICSI, IUI, infertility treatments, fertility preservation, and advanced genetic testing.GAUDIUMIVF Stock Price Movement
On Thursday, shares of Gaudium IVF and Women Health Limited edged higher in the market, gaining 2.00% to settle at ₹125.74. The equity finished robustly, with 187,323 shares recorded during the trading session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.